5
Theranos
submitted 2 days ago by @david 149
Overview
Theranos: 1 investigación pública y 248 afirmaciones.
Vistas generales de mapas
- 5Theranos - Elizabeth Holmes Hero Arc Fork
submitted 22 oct 2026 by @nineDan 203
OverviewThis map investigates the post-conviction legal proceedings and Elizabeth Holmes's personal defense trajectory. It details judicial deliberations over sentencing guideline calculations, victim hardship thresholds, and post-trial prison sentence reductions. Its arguments center on case law interpretations, jury verdicts, and Holmes's media efforts to reshape public perception.
Last generated 25 oct 2026, 18:55 by a member
Más información
Comparado 25 oct 2026, 18:55
Mapas
Comparando mapas…
Themes across the family
A broad read of every map in this family: the themes that run through them and how each map treats them. Structured scans give a more targeted side-by-side.
Dual Lab Operations and Commercial Analyzer Deception
2 de 2 mapasBoth maps highlight that Theranos maintained a fraudulent front by demonstrating proprietary Edison hardware while secretly running patient samples and proficiency checks on commercial machines.
M1Theranos
Emphasizes the clandestine acquisition of Siemens ADVIA analyzers and running separate lab workflows to deceive partners and pass certification.
M2Theranos - Elizabeth Holmes Hero Arc Fork
Shows how the secret use of third-party machines formed the basis of regulatory scrutiny and criminal fraud findings.
Quality Control Failures and Result Invalidation
2 de 2 mapasThe maps detail systemic quality control failures, intentional deletion of outlier data, and the subsequent mass voiding of tens of thousands of diagnostic results.
M1Theranos
Focuses on the operational scale of invalidations, including specific assay failures, deleted outliers, and hundreds of thousands of impacted Arizona results.
M2Theranos - Elizabeth Holmes Hero Arc Fork
Connects quality control failures and two-year retroactive test voids to regulatory sanctions under CLIA.
Legal, Sentencing, and Regulatory Accountability
2 de 2 mapasBoth maps track the severe regulatory and criminal repercussions faced by Theranos leadership, from CMS bans and HHS exclusions to federal prison sentences.
M1Theranos
Documents administrative exclusions by HHS and victim impact evidence presented in federal sentencing.
M2Theranos - Elizabeth Holmes Hero Arc Fork
Examines detailed judicial findings on sentencing guidelines, sentence reductions, and disparate trial outcomes between Holmes and Balwani.
Corporate Mythmaking and Narrative Control
2 de 2 mapasThe family explores how Elizabeth Holmes curated deceptive corporate artifacts and continued attempting to rehabilitate her public narrative post-trial.
M1Theranos
Concentrates on document alterations and the fabrication of third-party endorsements from pharmaceutical companies.
M2Theranos - Elizabeth Holmes Hero Arc Fork
Analyzes Holmes's ongoing media strategy and documentary participation to contest the narrative and clear her name.
Theranos operated parallel laboratory environments, using commercial analyzers behind the scenes while showcasing proprietary technology for investor demonstrations.
M1Theranos
C0203Secret Siemens dealConfirmado como correcto
Theranos purchased commercial Siemens ADVIA analyzers through a secret subsidiary to avoid suspicion from Siemens because their own technology failed.
Vinculada a la fuenteSignificancia AltaGemini
M1Theranos
C0226Theranos lab systems separateConfirmado como correcto
Theranos operated two separate lab systems: one for demonstrations to investors/partners using the Edison device, and another for actual patient results using commercial analyzers.
Vinculada a la fuenteSignificancia AltaClaude, Gemini
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0203Secret Siemens dealConfirmado como correcto
Vinculada a la fuenteSignificancia AltaGemini
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0226Dual lab systems usedConfirmado como correcto
Vinculada a la fuenteSignificancia AltaClaude, Gemini
Supervisory practices at Theranos routinely involved discarding quality control outliers to force failing test runs into passing thresholds.
M1Theranos
C0014Outlier data ignoredInvestigar con IA
Erika Cheung reported that Theranos supervisors instructed staff to delete or disregard outlier quality control data points to make runs pass.
InferidaSignificancia AltaClaude
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0093Data deleted from QC runs
The deletion of data points from QC runs on Edison devices was done so that the remaining average would pass internal thresholds.
InferidaSignificancia AltaGrok
Proficiency testing samples mandated by federal regulators were routed exclusively to third-party commercial machines to maintain laboratory certification.
M1Theranos
C0210Lab staff orderedConfirmado como correcto
Sunny Balwani ordered lab staff to run federal proficiency testing samples exclusively on third-party commercial analyzers rather than the Edison to maintain CLIA lab certification.
Vinculada a la fuenteSignificancia AltaGemini
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0210Balwani orders third-party analyzersConfirmado como correcto
Vinculada a la fuenteSignificancia AltaGemini
Desacuerdo0
Aún no hay puntos contrapuestos.
Theranos provides comprehensive quantitative accounting of consumer test orders, void rates, and restitution specifics from the Arizona regulatory action.
M1Theranos
Approximately 834,233 (exactly 10.6%) of the 7,862,146 test results provided by Theranos to Arizona consumers between 2013 and 2016 were ultimately voided or corrected.
InferidaSignificancia AltaGrok
Theranos - Elizabeth Holmes Hero Arc Fork focuses intensely on federal sentencing jurisprudence regarding zero-point offenders and the legal definition of substantial financial hardship.
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0039No victim experienced hardship
Judge Davila's conclusion was that the record did not establish any identified victim experienced the individualized “substantial financial hardship” required to disqualify Holmes under §4C1.1(a)(6).
InferidaSignificancia AltaChatGPT
Theranos treats internal findings of frequent test inaccuracy as an open question requiring investigation, whereas Theranos - Elizabeth Holmes Hero Arc Fork regards frequent inaccuracy as a known correct fact.
M1Theranos
C0224Test results frequently inaccurateInvestigar con IA
Internal documents and whistleblower testimony confirmed that Theranos's test results were frequently inaccurate.
InferidaSignificancia AltaClaude
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0224Inaccurate test resultsConfirmado como correcto
InferidaSignificancia AltaClaude
Theranos marks the occurrence of false negatives delaying patient treatment as under investigation, while Theranos - Elizabeth Holmes Hero Arc Fork labels it known correct.
M1Theranos
C0161False negatives delayed treatmentInvestigar con IA
Some Theranos patients received false negatives that delayed treatment.
InferidaSignificancia AltaClaude
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0161False negative resultsConfirmado como correcto
InferidaSignificancia AltaClaude
Theranos marks reports of the miniLab centrifuge exploding as requiring investigation, whereas Theranos - Elizabeth Holmes Hero Arc Fork establishes it as a known correct fact.
M1Theranos
C0201MiniLab centrifuge explodesInvestigar con IA
The miniLab's miniaturized centrifuge was known to occasionally explode.
InferidaSignificancia AltaGemini
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0201MiniLab centrifuge explodesConfirmado como correcto
InferidaSignificancia AltaGemini
Theranos labels the death by suicide of Chief Scientist Ian Gibbons as an unconfirmed claim needing investigation, while Theranos - Elizabeth Holmes Hero Arc Fork verifies it as known correct.
M1Theranos
C0232Chief Scientist died by suicideInvestigar con IA
Ian Gibbons, Theranos's Chief Scientist, died by suicide in May 2013.
InferidaSignificancia AltaClaude
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0232Ian Gibbons deathConfirmado como correcto
InferidaSignificancia AltaClaude
- https://medium.com/@sb/theranos-more-than-a-pin-prick-2f1b4b0e5c9a
M1Theranos
C0226Theranos lab systems separateConfirmado como correcto
Theranos operated two separate lab systems: one for demonstrations to investors/partners using the Edison device, and another for actual patient results using commercial analyzers.
Vinculada a la fuenteSignificancia AltaClaude, Gemini
M1Theranos
C0210Lab staff orderedConfirmado como correcto
Sunny Balwani ordered lab staff to run federal proficiency testing samples exclusively on third-party commercial analyzers rather than the Edison to maintain CLIA lab certification.
Vinculada a la fuenteSignificancia AltaGemini
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0226Dual lab systems usedConfirmado como correcto
Vinculada a la fuenteSignificancia AltaClaude, Gemini
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0210Balwani orders third-party analyzersConfirmado como correcto
Vinculada a la fuenteSignificancia AltaGemini
- https://www.hhs.gov/about/agencies/dab/decisions/board-decisions/2026/board-dab-3222/index.html
M1Theranos
C0094Holmes excluded from healthcare
On December 29, 2023, the HHS Inspector General excluded Elizabeth Holmes from participation in all federal health-care programs for 90 years. An administrative law judge upheld this exclusion on April 25, 2025, and the HHS Departmental Appeals Board subsequently affirmed it in 2026.
Vinculada a la fuenteSignificancia AltaChatGPT
M2Theranos - Elizabeth Holmes Hero Arc Fork
In DAB No. 3222, issued in 2026, the Department of Health and Human Services Departmental Appeals Board upheld Elizabeth Holmes’s exclusion from all federal healthcare programs for 90 years.
Vinculada a la fuenteSignificancia AltaChatGPT
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0104HHS Appeals Board finds fraud
The HHS Appeals Board found the required nexus for fraud “in connection with” healthcare delivery in Theranos’s blood-testing business, Walgreens and Safeway agreements, representations about analyzers and patient services, and the health-related statements incorporated into the investor-fraud counts.
Vinculada a la fuenteSignificancia AltaChatGPT
- https://scholarworks.uark.edu/cgi/viewcontent.cgi?article=1109&context=acctuht
M1Theranos
C0203Secret Siemens dealConfirmado como correcto
Theranos purchased commercial Siemens ADVIA analyzers through a secret subsidiary to avoid suspicion from Siemens because their own technology failed.
Vinculada a la fuenteSignificancia AltaGemini
M2Theranos - Elizabeth Holmes Hero Arc Fork
C0203Secret Siemens dealConfirmado como correcto
Vinculada a la fuenteSignificancia AltaGemini
Preguntas abiertas compartidas0
No hay preguntas abiertas compartidas.
Discussion
Escribe @m para etiquetar un mapa en un comentario, o menciona a alguien con @username.
Aún no hay comentarios.